Seeking Alpha46m
Novo Nordisk: The Street Is Not Seeing The Growth Acceleration Potential
However, Novo Nordisk is in a peculiar situation where it cannot produce enough of its GLP-1 products Wegovy and ...
Novo Nordisk and Nanovation sign $600m deal in rare and cardiometabolic diseases
NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Multiple Strong Catalysts And Attractive Valuation Make Novo Nordisk A Buy
Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial
Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...
NationofChange1d
Bernie Sanders calls out Big Pharma over exorbitant drug prices: Novo Nordisk’s $900+ charge for a drug that could be sold for $100
As Novo Nordisk rakes in billions, Sen. Bernie Sanders and public health advocates demand answers on why U.S. patients are charged sky-high prices for life-saving drugs like Ozempic while generics ...
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications
NanoVation Therapeutics partners with Novo Nordisk to develop genetic medicines for cardiometabolic and rare diseases, utilizing NanoVation's lipid nanoparticle technology. The deal includes research ...
Vermont Business Magazine2d
Ahead of Novo Nordisk hearing, 250 clinicians demand affordable access to Ozempic and Wegovy
Novo Nordisk CEO Lars Jørgensen will testify about the high cost of Ozempic and Wegovy at an upcoming HELP Committee hearing on September 24th.
Novo Nordisk’s new weight-loss pill Amycretin beats Wegovy in early trial
The highly anticipated new obesity pill shows the potential for greater and faster weight loss than Wegovy. There is a new ...
Maker of Ozempic, Wegovy sues Minnesota clinic over knockoff weight-loss medication
One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...